Idera Pharmaceuticals (NASDAQ: IDRA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Idera Pharmaceuticals (NASDAQ: IDRA) through any online brokerage.
The latest price target for Idera Pharmaceuticals (NASDAQ: IDRA) was reported by Wedbush on Friday, March 19, 2021. The analyst firm set a price target for 1.00 expecting IDRA to rise to within 12 months (a possible 128.31% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Idera Pharmaceuticals (NASDAQ: IDRA) is $0.438 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Idera Pharmaceuticals.
Idera Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Idera Pharmaceuticals.
Idera Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.